
Aibion Technologies specializes in AI-based solutions for medical data processing, focusing on digital pathology, genetic research, and COVID-19 data management. Their products include a digital pathology PACS, a comprehensive LIMS for genetic research, and a COVID-19 registry, all designed to enhance diagnostic accuracy and streamline workflows in healthcare. With a commitment to improving patient outcomes through innovative technology, Aibion has established itself as a key player in the Med Tech space since its inception in 2020, demonstrating significant traction with increased laboratory productivity and faster diagnostic processes.

Aibion Technologies specializes in AI-based solutions for medical data processing, focusing on digital pathology, genetic research, and COVID-19 data management. Their products include a digital pathology PACS, a comprehensive LIMS for genetic research, and a COVID-19 registry, all designed to enhance diagnostic accuracy and streamline workflows in healthcare. With a commitment to improving patient outcomes through innovative technology, Aibion has established itself as a key player in the Med Tech space since its inception in 2020, demonstrating significant traction with increased laboratory productivity and faster diagnostic processes.
Sector: MedTech / medical AI
Founded: 2020
Headquarters / Operations: Dubai with development activity in Minsk
Flagship product: HistoCloud digital pathology PACS / WSI viewer
Team size (reported): 9 employees
Funding (reported): Pre-Seed; total ~$50,000 (USD) reported
Medical image management and analysis, laboratory information management for genetic research, medical data annotation and AI model evaluation.
2020
Healthcare / MedTech
50000.00 USD
“EXPERT DOJO listed as lead/identified investor in reported early round”